Evidence map›Paper›PMID 41058252›Full record

ArticleCancer reports (Hoboken, N.J.)2025

Bioinformatic Characterization of Genes That Are Correlated to the Progression of Breast Cancer to Breast Cancer Brain Metastasis.

Mageshree Pillay, Oliver Tendayi Zishiri

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mageshree PillayDiscipline of Genetics, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0002-9223-3340
Oliver Tendayi ZishiriDiscipline of Genetics, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0002-9741-4124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of breast cancer is escalating into millions of cases annually all over the world with hundreds of thousands of deaths recorded each year. It has been well established that breast cancer is caused by both genetic and non-genetic factors. However, there is a paucity of information on breast cancer that metastasizes to the brain. The molecular process of carcinogenesis in breast cancer brain metastasis (BCBM) is yet to be fully characterized.

aimsIt is crucial to identify genes linked with breast cancer brain metastasis development and prognosis. This study sought out to decipher putative pathogenic and predictive genes in BCBM using bioinformatic analysis of public datasets. METHODS AND

resultsThe bioinformatic analysis utilized the GSE125989, GSE191230 and GSE52604 datasets. GEO2R was used for the identification of DEGs. Venn was employed to identify the common up-regulated and down-regulated genes. The STRING website was used to create the protein-protein interaction (PPI) network of the DEGs, which was then represented using Cytoscape. A Kaplan-Meier (KM) plotter was used to conduct the hub gene survival analysis. Validation of the hub genes was carried out using UALCAN. The heat map was then visualized using Fun Rich. The tumor infiltrating analysis was carried out using TIMER. Using DAVID, the GO and KEGG analyses were conducted. The structure of the hub genes was obtained from the human protein atlas. A total of 4 DEGs was identified. A PPI network was developed, one significant module was identified, and 3 clusters were selected. Ten hub genes were discovered using Cytoscape's MCC ranking technique. Ten hub genes (IL6, INS, TNF, PPARG, PPARA, SLC2A4, PPARGC1A, IRS1, LEP and ADIPOQ) were all associated with the progression of BCBM.

conclusionThe study's findings revealed that the hub genes investigated could be possibly vital genes in determining the molecular mechanism of BCBM.

Indexed as

Biomarkers, TumorBrain NeoplasmsBreast NeoplasmsComputational BiologyDatabases, GeneticDisease ProgressionFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansPrognosisProtein Interaction MapsBiomarkers, Tumorbreast neoplasmsbreast tumorssurvival

Identifiers

PMID41058252
PMCPMC12504803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.